Shiotani T, Tohyama K, Murase K, Ishihara S, Kameyama T, Yamasaki T, Hatanaka S, Kojima H, Takasu Y, Nabeshima T
Tokyo Research and Development Center, Daiichi Pharmaceutical Co. Ltd., Japan.
J Neural Transm Gen Sect. 1992;90(2):103-11. doi: 10.1007/BF01250792.
The effects of nefiracetam, [N-(2,6-dimethyl-phenyl)-2-(2-oxo-pyrrolidinyl)acetamide, DM-9384], a cyclic derivative of GABA, were investigated in the cycloheximide (CXM)-induced amnesia animal model using the passive avoidance task. Pre-training administration of DM-9384 attenuated the CXM-induced amnesia as indicated by prolongation of step-down latency. It protected against CXM-induced inhibition of choline acetyltransferase activity in the cerebral cortex. These results suggest that DM-9384 attenuates CXM-induced amnesia by interacting with AChergic neuronal system and enhancing protein synthesis in the brain.
使用被动回避任务,在环己酰亚胺(CXM)诱导的遗忘动物模型中研究了GABA的环状衍生物奈非西坦[N-(2,6-二甲基苯基)-2-(2-氧代吡咯烷基)乙酰胺,DM-9384]的作用。如降低潜伏期的延长所示,DM-9384的预训练给药减轻了CXM诱导的遗忘。它可防止CXM诱导的大脑皮质胆碱乙酰转移酶活性的抑制。这些结果表明,DM-9384通过与胆碱能神经系统相互作用并增强大脑中的蛋白质合成来减轻CXM诱导的遗忘。